The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
n/a | 37 | 50 | 73 |
Growth
|
n/a | 91 | 83 | 23 |
Safety
|
n/a | 45 | 32 | 29 |
Sentiment
|
n/a | 5 | 20 | 87 |
|
n/a | 32 | 33 | 65 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
n/a | 20 | 79 | 64 |
Opinions Change
|
n/a | 40 | 50 | 87 |
Pro Holdings
|
n/a | 1 | 14 | 55 |
Market Pulse
|
n/a | 22 | 27 | 46 |
Sentiment
|
n/a | 5 | 20 | 87 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
n/a | 37 | 50 | 73 |
Growth
|
n/a | 91 | 83 | 23 |
|
n/a | 45 | 32 | 29 |
Combined
|
n/a | 78 | 67 | 29 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
n/a | 35 | 35 | 32 |
Price vs. Earnings (P/E)
|
n/a | 82 | 71 | 54 |
Price vs. Book (P/B)
|
n/a | 9 | 35 | 74 |
Dividend Yield
|
n/a | 1 | 1 | 1 |
Value
|
n/a | 37 | 50 | 73 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
n/a | 85 | 86 | 81 |
Profit Growth
|
n/a | 69 | 72 | 48 |
Capital Growth
|
n/a | 100 | 95 | 16 |
Stock Returns
|
n/a | 13 | 13 | 25 |
Growth
|
n/a | 91 | 83 | 23 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
n/a | 13 | 16 | 8 |
Refinancing
|
n/a | 82 | 73 | 81 |
Liquidity
|
n/a | 33 | 34 | 32 |
|
n/a | 45 | 32 | 29 |
Discover high‑ranked alternatives to Akoya Biosciences and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.